FierceBiotech |
Digital health player Amalgam Rx launches with Type 2 diabetes app
FierceBiotech Amalgam Rx, a new company focusing on digital therapies for chronic diseases, launched Monday with the first FDA-cleared mobile app that automates the titration—or dose—of basal insulin for patients with Type 2 diabetes. The prescription-only app ... WellDoc Founders Launch FDA-Cleared Mobile Insulin Titration App for Diabetes Management |
Social Plugin